Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.
about
Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionCytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysisFrom cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.Duodenal administered seal oil for patients with subjective food hypersensitivity: an explorative open pilot studyDo psychological factors predict symptom severity in patients with subjective food hypersensitivity?Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea.What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor.Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.Irritable bowel syndrome, gut microbiota and probiotics.Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome.Can a mathematical model be used to estimate the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome?Post-infectious and non post-infectious irritable bowel syndrome: A comparative study.Long-term Clinical Course of Post-infectious Irritable Bowel Syndrome After Shigellosis: A 10-year Follow-up StudyPostinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.The role of eosinophils and mast cells in intestinal functional disease.The role of human defensins in gastrointestinal diseases.Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis.Is irritable bowel syndrome an organic disorder?Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment.Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria.Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach.Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in Australians deployed abroad.Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all?Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico.[Functional gastrointestinal diseases].A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
P2860
Q26768264-4B6BE104-3C33-488B-85AC-DDFD19E760C5Q27011652-CBF5D8FD-9131-4128-9548-A0324FBFF2E8Q34298260-D6F6FA4B-2291-4FD6-8B6F-83B6DA8EE6A0Q34346102-3832C3D4-C7F8-4A2E-B381-92C7DE8BFF10Q34432365-662944DD-D017-4DF4-9011-C39753875AE1Q34619223-223C65D4-B136-484E-BF78-DE0E7AC65064Q34709083-3C30E31F-B188-44EA-BA5F-83A09157FE13Q34976203-51509383-B01B-49F3-A5E7-43B772A61014Q35006863-06E681AC-646A-4A5F-8A3E-1F84EA105E92Q35117195-6A97C854-6F01-4239-9701-D07F7DD72E90Q35161373-40E0981D-51B6-4E2D-BA94-1E83E5BF2705Q35430640-8E851999-E35D-49FE-B42D-A00B4DC164E4Q35885888-16CEC92A-7432-416B-975F-79D9DA56C701Q36697730-302177EE-C950-4985-8714-D0EDED30A1BFQ37058979-A51BC207-AA0E-4B22-BE5E-E42F3E82C6D2Q37099359-B6775FE7-84EB-4546-B496-8F2DE7A34B12Q37873352-73B6E6A8-268F-464D-9CC4-673112A43073Q37947675-CC84F5CA-7096-409E-92EE-2124F81C0E44Q38003044-E203FF4D-8F05-4FB1-B299-54327556CFD8Q38191561-4787DA92-EE35-4B23-BDC4-4C34D0CE6C53Q38192048-36394A98-9A37-4E61-8CB1-F90C0159FCCDQ39604551-D5D019D1-B10F-45B3-980A-F510DA41F55BQ42251511-46748BAA-AD4F-4265-BB79-2838018DB655Q45155534-DAFA9AA1-0DD1-46A3-827F-8D8347659F4DQ47328049-BC3F8CF5-76F8-43B6-B181-BB2905586614Q50972910-2D7ECCD0-C828-4327-B6D6-3491F2108FB8Q54705452-7604FF47-9BEB-42DF-8F55-0367F1954834Q55063629-35528C3C-EC94-4156-83BE-6F774DA8B4A1
P2860
Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@ast
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@en
type
label
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@ast
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@en
prefLabel
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@ast
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@en
P2860
P356
P1476
Post-Infectious Irritable Bowe ...... IBS and Functional Dyspepsia.
@en
P2093
Kok-Ann Gwee
P2860
P356
10.5056/JNM.2010.16.1.30
P577
2010-01-31T00:00:00Z